SEC Form 4 · accession 0001127602-18-009048

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman & CEO · Director

Period of report

Feb 26, 2018

Accepted (ET)

Feb 28, 2018 · 3:39 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 26, 2018	S	100	$108.14	D	311,343	D
Common Stock	Feb 26, 2018	S	200	$108.16	D	311,143	D
Common Stock	Feb 26, 2018	S	100	$108.31	D	311,043	D
Common Stock	Feb 26, 2018	S	30	$108.345	D	311,013	D
Common Stock	Feb 26, 2018	S	201	$108.36	D	310,812	D
Common Stock	Feb 26, 2018	S	100	$108.375	D	310,712	D
Common Stock	Feb 26, 2018	S	270	$108.38	D	310,442	D
Common Stock	Feb 26, 2018	S	200	$108.385	D	310,242	D
Common Stock	Feb 26, 2018	S	200	$108.40	D	310,042	D
Common Stock	Feb 26, 2018	S	500	$108.41	D	309,542	D
Common Stock	Feb 26, 2018	S	200	$108.42	D	309,342	D
Common Stock	Feb 26, 2018	S	100	$108.435	D	309,242	D
Common Stock	Feb 26, 2018	S	200	$108.445	D	309,042	D
Common Stock	Feb 26, 2018	S	100	$108.46	D	308,942	D
Common Stock	Feb 26, 2018	S	200	$108.465	D	308,742	D
Common Stock	Feb 26, 2018	S	17	$108.47	D	308,725	D
Common Stock	Feb 26, 2018	S	200	$108.48	D	308,525	D
Common Stock	Feb 26, 2018	S	100	$108.49	D	308,425	D
Common Stock	Feb 26, 2018	S	311	$108.495	D	308,114	D
Common Stock	Feb 26, 2018	S	300	$108.50	D	307,814	D
Common Stock	Feb 26, 2018	S	300	$108.51	D	307,514	D
Common Stock	Feb 26, 2018	S	100	$108.515	D	307,414	D
Common Stock	Feb 26, 2018	S	200	$108.55	D	307,214	D
Common Stock	Feb 26, 2018	S	200	$108.555	D	307,014	D

No Table II lines on this filing.